Publication | Closed Access
Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway
173
Citations
43
References
2022
Year
Renal Tubular FerroptosisMetabolic SyndromeRenal FunctionRenal DiseaseBiochemistryMedicineDiabetesChronic Kidney DiseaseDiabetic Kidney DiseaseAmpk/nrf2 PathwayPharmacologyNephrologyKidney ResearchOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1